首页 > 最新文献

Medecine et maladies infectieuses最新文献

英文 中文
Influence of information sources on vaccine hesitancy and practices 信息来源对疫苗犹豫和做法的影响
IF 5 Q3 Medicine Pub Date : 2020-11-01 DOI: 10.1016/j.medmal.2020.01.010
Jalal Charron, Arnaud Gautier, Christine Jestin

Introduction

Many factors influence vaccination practices and attitudes. This study aimed to identify vaccine information sources used by parents of children aged 1–15 years to get a better understanding of the relation between vaccine information sources, practices for two vaccines (MMR, HBV), vaccine acceptance, and vaccine hesitancy.

Methods

A total of 3938 parents, drawn by random sampling, were interviewed by telephone as part of the “2016 health barometer” survey. Vaccine information sources were described and analyzed according to socio-demographic variables. Multivariate logistic regression models were then built to explain vaccine information sources usage, vaccination practices and attitudes.

Results

Healthcare professionals (HCP), the Internet, and relatives were the three main vaccine information sources. Vaccination practices and acceptance were better when parents were getting information from HCPs compared with parents getting information from the Internet or relatives. Besides, getting information from the three different types of sources was associated with the highest rate of vaccine hesitancy: 70.9% (OR = 4.6; P < 0.0001) versus 34.6% among parents getting information from HCPs only.

Conclusion

Those results suggest an interest in providing quality information about vaccination on the Internet. The primary role of HCPs in vaccination decision is once again demonstrated.

许多因素影响疫苗接种的做法和态度。本研究旨在确定1-15岁儿童家长使用的疫苗信息来源,以更好地了解疫苗信息来源、两种疫苗(MMR、HBV)的使用情况、疫苗接受度和疫苗犹豫之间的关系。方法随机抽取3938名家长进行电话访谈,作为“2016年健康晴雨表”调查的一部分。根据社会人口变量描述和分析疫苗信息来源。然后建立多元逻辑回归模型来解释疫苗信息源的使用、疫苗接种做法和态度。结果卫生专业人员、互联网和亲属是疫苗信息的三个主要来源。与父母从互联网或亲戚那里获得信息相比,父母从卫生保健人员那里获得信息时,接种疫苗的做法和接受程度更好。此外,从三种不同来源获取信息与疫苗犹豫率最高相关:70.9% (OR = 4.6;P & lt;0.0001),而仅从HCPs获取信息的家长占34.6%。结论这些结果表明,有兴趣在互联网上提供有关疫苗接种的高质量信息。HCPs在疫苗接种决策中的主要作用再次得到证实。
{"title":"Influence of information sources on vaccine hesitancy and practices","authors":"Jalal Charron,&nbsp;Arnaud Gautier,&nbsp;Christine Jestin","doi":"10.1016/j.medmal.2020.01.010","DOIUrl":"10.1016/j.medmal.2020.01.010","url":null,"abstract":"<div><h3>Introduction</h3><p>Many factors influence vaccination practices and attitudes. This study aimed to identify vaccine information sources used by parents of children aged 1–15 years to get a better understanding of the relation between vaccine information sources, practices for two vaccines (MMR, HBV), vaccine acceptance, and vaccine hesitancy.</p></div><div><h3>Methods</h3><p>A total of 3938 parents, drawn by random sampling, were interviewed by telephone as part of the “2016 health barometer” survey. Vaccine information sources were described and analyzed according to socio-demographic variables. Multivariate logistic regression models were then built to explain vaccine information sources usage, vaccination practices and attitudes.</p></div><div><h3>Results</h3><p>Healthcare professionals (HCP), the Internet, and relatives were the three main vaccine information sources. Vaccination practices and acceptance were better when parents were getting information from HCPs compared with parents getting information from the Internet or relatives. Besides, getting information from the three different types of sources was associated with the highest rate of vaccine hesitancy: 70.9% (OR<!--> <!-->=<!--> <!-->4.6; <em>P</em> <!-->&lt;<!--> <!-->0.0001) versus 34.6% among parents getting information from HCPs only.</p></div><div><h3>Conclusion</h3><p>Those results suggest an interest in providing quality information about vaccination on the Internet. The primary role of HCPs in vaccination decision is once again demonstrated.</p></div>","PeriodicalId":18464,"journal":{"name":"Medecine et maladies infectieuses","volume":"50 8","pages":"Pages 727-733"},"PeriodicalIF":5.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.medmal.2020.01.010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37652687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 64
HIV self-testing in adolescents living in Sub-Saharan Africa 撒哈拉以南非洲青少年艾滋病毒自我检测情况
IF 5 Q3 Medicine Pub Date : 2020-11-01 DOI: 10.1016/j.medmal.2020.07.007
S. Tonen-Wolyec , D. Koyalta , R.-S. Mboumba Bouassa , M. Filali , S. Batina-Agasa , L. Bélec

Less than 20% of African adolescents aged 10–19 years are aware of their HIV status, whereas HIV screening remains the gateway to care and while AIDS has become the leading cause of death among adolescents in Sub-Saharan Africa. According to the UNAIDS target, scalable HIV testing strategies specific to various age groups, populations, and geographical areas must be implemented to end the AIDS epidemic by 2030. Many African countries have implemented policies supporting HIV self-testing (HIVST). Evidence of practicability and efficiency of HIVST in Sub-Saharan Africa settings has been reported, including HIVST data among adolescents. Adapted strategies of HIVST are urgently needed to promote HIV testing among adolescents living in sub-Saharan Africa.

不到20%的10-19岁非洲青少年了解自己的艾滋病毒状况,而艾滋病毒筛查仍然是获得护理的途径,而艾滋病已成为撒哈拉以南非洲青少年死亡的主要原因。根据艾滋病规划署的目标,必须实施针对不同年龄组、人口和地理区域的可扩展的艾滋病毒检测战略,以便到2030年结束艾滋病流行。许多非洲国家实施了支持艾滋病毒自我检测的政策。已经有证据表明艾滋病毒传播在撒哈拉以南非洲环境中的实用性和有效性,包括青少年中的艾滋病毒传播数据。迫切需要适应艾滋病毒传播的战略,以促进生活在撒哈拉以南非洲的青少年进行艾滋病毒检测。
{"title":"HIV self-testing in adolescents living in Sub-Saharan Africa","authors":"S. Tonen-Wolyec ,&nbsp;D. Koyalta ,&nbsp;R.-S. Mboumba Bouassa ,&nbsp;M. Filali ,&nbsp;S. Batina-Agasa ,&nbsp;L. Bélec","doi":"10.1016/j.medmal.2020.07.007","DOIUrl":"10.1016/j.medmal.2020.07.007","url":null,"abstract":"<div><p>Less than 20% of African adolescents aged 10–19 years are aware of their HIV status, whereas HIV screening remains the gateway to care and while AIDS has become the leading cause of death among adolescents in Sub-Saharan Africa. According to the UNAIDS target, scalable HIV testing strategies specific to various age groups, populations, and geographical areas must be implemented to end the AIDS epidemic by 2030. Many African countries have implemented policies supporting HIV self-testing (HIVST). Evidence of practicability and efficiency of HIVST in Sub-Saharan Africa settings has been reported, including HIVST data among adolescents. Adapted strategies of HIVST are urgently needed to promote HIV testing among adolescents living in sub-Saharan Africa.</p></div>","PeriodicalId":18464,"journal":{"name":"Medecine et maladies infectieuses","volume":"50 8","pages":"Pages 648-651"},"PeriodicalIF":5.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.medmal.2020.07.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38275463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Infarctus splénique révélant un accès palustre à Plasmodium vivax 脾梗死揭示间日疟原虫的沼泽途径
IF 5 Q3 Medicine Pub Date : 2020-11-01 DOI: 10.1016/j.medmal.2020.04.012
S. El Aoud, C. Morin, S. Dagnet Basses, A. Selmaoui, B. Boutin, L. Thomas
{"title":"Infarctus splénique révélant un accès palustre à Plasmodium vivax","authors":"S. El Aoud,&nbsp;C. Morin,&nbsp;S. Dagnet Basses,&nbsp;A. Selmaoui,&nbsp;B. Boutin,&nbsp;L. Thomas","doi":"10.1016/j.medmal.2020.04.012","DOIUrl":"10.1016/j.medmal.2020.04.012","url":null,"abstract":"","PeriodicalId":18464,"journal":{"name":"Medecine et maladies infectieuses","volume":"50 8","pages":"Pages 746-747"},"PeriodicalIF":5.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.medmal.2020.04.012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37857141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Ibrutinib, a Bruton's tyrosine kinase inhibitor, a new risk factor for cryptococcosis 伊鲁替尼,布鲁顿酪氨酸激酶抑制剂,隐球菌病的新危险因素
IF 5 Q3 Medicine Pub Date : 2020-11-01 DOI: 10.1016/j.medmal.2020.07.005
J. Brochard , F. Morio , J. Mahe , P. Le Pape , T. Guimard , B. Mahe , M. Leterrier , M. Morrier , F. Raffi , D. Boutoille

Purpose

Invasive fungal diseases and especially Cryptococcus neoformans infections are increasingly reported in patients with hematological malignancies receiving ibrutinib, a Bruton's tyrosine kinase inhibitor.

Patients and method

We reported three additional cases and reviewed 16 previous published cases together with cases from the international pharmacovigilance database.

Results

Patients were mainly treated for chronic lymphocytic leukemia. Cryptococcosis mostly occurred during the first six months (66%) and especially the first two months (44%) of treatment. Clinical presentation is often pulmonary (68%) and the outcome is usually favorable despite ibrutinib continuation.

Conclusion

Clinicians must be aware of this infection in patients with hematological malignancies on ibrutinib.

目的:在接受依鲁替尼(一种布鲁顿酪氨酸激酶抑制剂)治疗的血液系统恶性肿瘤患者中,侵袭性真菌疾病,特别是新型隐球菌感染的报道越来越多。患者和方法我们报告了另外3例病例,并回顾了以前发表的16例病例以及国际药物警戒数据库中的病例。结果本组患者以慢性淋巴细胞白血病为主。隐球菌病主要发生在治疗的前6个月(66%),尤其是治疗的前2个月(44%)。临床表现通常是肺部(68%),尽管继续使用依鲁替尼,结果通常是有利的。结论临床医生应注意依鲁替尼治疗的恶性血液病患者的这种感染。
{"title":"Ibrutinib, a Bruton's tyrosine kinase inhibitor, a new risk factor for cryptococcosis","authors":"J. Brochard ,&nbsp;F. Morio ,&nbsp;J. Mahe ,&nbsp;P. Le Pape ,&nbsp;T. Guimard ,&nbsp;B. Mahe ,&nbsp;M. Leterrier ,&nbsp;M. Morrier ,&nbsp;F. Raffi ,&nbsp;D. Boutoille","doi":"10.1016/j.medmal.2020.07.005","DOIUrl":"10.1016/j.medmal.2020.07.005","url":null,"abstract":"<div><h3>Purpose</h3><p>Invasive fungal diseases and especially Cryptococcus neoformans infections are increasingly reported in patients with hematological malignancies receiving ibrutinib, a Bruton's tyrosine kinase inhibitor.</p></div><div><h3>Patients and method</h3><p>We reported three additional cases and reviewed 16 previous published cases together with cases from the international pharmacovigilance database.</p></div><div><h3>Results</h3><p>Patients were mainly treated for chronic lymphocytic leukemia. Cryptococcosis mostly occurred during the first six months (66%) and especially the first two months (44%) of treatment. Clinical presentation is often pulmonary (68%) and the outcome is usually favorable despite ibrutinib continuation.</p></div><div><h3>Conclusion</h3><p>Clinicians must be aware of this infection in patients with hematological malignancies on ibrutinib.</p></div>","PeriodicalId":18464,"journal":{"name":"Medecine et maladies infectieuses","volume":"50 8","pages":"Pages 742-745"},"PeriodicalIF":5.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.medmal.2020.07.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38249824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Antimicrobial resistance in N’Djamena (Chad): Four-year experience of the French Forward Medical and Surgical Team engaged in the “Barkhane Operation” 恩贾梅纳(乍得)的抗菌素耐药性:法国前沿医疗和外科小组参与"巴克哈内手术"的四年经验
IF 5 Q3 Medicine Pub Date : 2020-11-01 DOI: 10.1016/j.medmal.2019.12.009
M. Cardinale , F. Bourbotte-Salmon , C. Scheiwe , S. Boulezaz , M. Ridet , P. Laitselart

Objectives

Knowledge of local antimicrobial resistance (AMR) patterns is required for effective empirical treatment of bacterial diseases. Very little is known about current resistance patterns of common pathogenic bacteria in the African region and particularly in the Sahel region. We aimed to describe the local bacterial epidemiology and to determine whether French recommendations for empirical treatment could be implemented.

Patients and methods

We performed a single-center observational study. Data was collected retrospectively from the Forward Medical and Surgical Center (FFMSC) bacterial database from January 2015 to December 2018. All bacteriological analyses, negative or positive, were included.

Results

A total of 2194 samples were analyzed. Infectious diseases were urinary tract infections (20.8%), bone and joint infections (20.4%), skin infections of chronic wounds (13.4%), soft tissue abscesses (13%), and gastroenteritis (10.8%). The most frequent infections were enterobacterial infections (43.6%) and staphylococcal infections (31.1%). The prevalence of AMR was 32.1%. Significantly more ESBL-producing bacteria (41.3%) were observed in the Chadian population than in the French population in N’djamena (6.3%) (P < 0.001).

Conclusions

We reported a high rate of ESBL-producing bacteria in N’Djamena. The use of empirical antibiotic therapies in the FFMSC may thus be questioned: French recommendations cannot be implemented in such setting and the use of carbapenems or new anti-ESBL antibiotics should be considered. Prospective studies are required to conclude.

目的了解局部抗菌素耐药性(AMR)模式是有效治疗细菌性疾病的必要条件。目前对非洲地区,特别是萨赫勒地区常见致病菌的耐药模式知之甚少。我们的目的是描述当地的细菌流行病学,并确定法国建议的经验性治疗是否可以实施。患者和方法我们进行了一项单中心观察性研究。回顾性收集2015年1月至2018年12月前沿医学外科中心(FFMSC)细菌数据库中的数据。所有细菌分析,阴性或阳性,包括在内。结果共分析样品2194份。感染性疾病为尿路感染(20.8%)、骨和关节感染(20.4%)、慢性伤口皮肤感染(13.4%)、软组织脓肿(13%)和肠胃炎(10.8%)。最常见的感染是肠杆菌感染(43.6%)和葡萄球菌感染(31.1%)。AMR患病率为32.1%。在恩贾梅纳,乍得人群中发现的产esbl细菌(41.3%)明显多于法国人群(6.3%)(P <0.001)。结论我们报道了恩贾梅纳地区产esbl细菌的高发率。因此,在FFMSC中使用经经性抗生素治疗可能会受到质疑:法国的建议不能在这种情况下实施,应考虑使用碳青霉烯类或新的抗esbl抗生素。需要前瞻性研究来得出结论。
{"title":"Antimicrobial resistance in N’Djamena (Chad): Four-year experience of the French Forward Medical and Surgical Team engaged in the “Barkhane Operation”","authors":"M. Cardinale ,&nbsp;F. Bourbotte-Salmon ,&nbsp;C. Scheiwe ,&nbsp;S. Boulezaz ,&nbsp;M. Ridet ,&nbsp;P. Laitselart","doi":"10.1016/j.medmal.2019.12.009","DOIUrl":"10.1016/j.medmal.2019.12.009","url":null,"abstract":"<div><h3>Objectives</h3><p>Knowledge of local antimicrobial resistance (AMR) patterns is required for effective empirical treatment of bacterial diseases. Very little is known about current resistance patterns of common pathogenic bacteria in the African region and particularly in the Sahel region. We aimed to describe the local bacterial epidemiology and to determine whether French recommendations for empirical treatment could be implemented.</p></div><div><h3>Patients and methods</h3><p>We performed a single-center observational study. Data was collected retrospectively from the Forward Medical and Surgical Center (FFMSC) bacterial database from January 2015 to December 2018. All bacteriological analyses, negative or positive, were included.</p></div><div><h3>Results</h3><p>A total of 2194 samples were analyzed. Infectious diseases were urinary tract infections (20.8%), bone and joint infections (20.4%), skin infections of chronic wounds (13.4%), soft tissue abscesses (13%), and gastroenteritis (10.8%). The most frequent infections were enterobacterial infections (43.6%) and staphylococcal infections (31.1%). The prevalence of AMR was 32.1%. Significantly more ESBL-producing bacteria (41.3%) were observed in the Chadian population than in the French population in N’djamena (6.3%) (<em>P</em> <!-->&lt;<!--> <!-->0.001).</p></div><div><h3>Conclusions</h3><p>We reported a high rate of ESBL-producing bacteria in N’Djamena. The use of empirical antibiotic therapies in the FFMSC may thus be questioned: French recommendations cannot be implemented in such setting and the use of carbapenems or new anti-ESBL antibiotics should be considered. Prospective studies are required to conclude.</p></div>","PeriodicalId":18464,"journal":{"name":"Medecine et maladies infectieuses","volume":"50 8","pages":"Pages 665-669"},"PeriodicalIF":5.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.medmal.2019.12.009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37624523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Emerging extensively drug-resistant bacteria (eXDR) in France in 2018 2018年法国出现广泛耐药细菌(eXDR)
IF 5 Q3 Medicine Pub Date : 2020-11-01 DOI: 10.1016/j.medmal.2020.01.011
M. Colomb-Cotinat , S. Soing-Altrach , A. Leon , Y. Savitch , I. Poujol , T. Naas , V. Cattoir , A. Berger-Carbonne , L. Dortet , the CPIAS network

Objective

This 2018 report of Healthcare-Associated Infections Early Warning and Response System (HAI-EWRS) notifications of carbapenemase-producing Enterobacteriaceae (CPE) or glycopeptide-resistant Enterococcus faecium (GRE), and of strains analysed by the National Reference Center for anti-microbial resistance (NRC) aimed to describe the epidemiology of emerging extensively drug-resistant bacteria (eXDR) in France and control measures implemented in hospital settings.

Patients and methods

All HAI-EWRS notifications of eXDR received at the national level and all eXDR strains received at the NRC between January 1, 2018 and January 31, 2018 were analysed. Variables analysed were number of cases, number of strains, resistance mechanism, sample type, link with a foreign country, and control measures implemented.

Results

In 2018, 1704 CPE notifications and 315 GRE notifications were reported in France, with an increasing trend since 2012 (× 6 for CPE, × 3 for GRE), from respectively 364 and 155 hospitals (+66% for CPE, +57% for GRE since 2012). eXDR strains were mainly isolated from rectal screening swabs. Notifications with patients receiving standard precautions were more often associated with outbreaks than notifications with patients receiving contact precautions at admission. NRC received 2674 CPE strains and 775 GRE strains in 2018 (× 8.3 and × 2.8 compared with 2012).

Conclusion

The increasing annual number of eXDR notifications and eXDR strains received by the NRC is multifactorial but reflects a worrying spread of eXDR in France. The number of infections remains low, but this article shows that existing recommendations are not fully implemented.

本2018年医疗保健相关感染预警和反应系统(HAI-EWRS)关于产碳青霉烯酶肠杆菌科(CPE)或耐糖肽类屎肠球菌(GRE)的报告,以及国家抗微生物药物耐药性参考中心(NRC)分析的菌株,旨在描述法国新出现的广泛耐药细菌(eXDR)的流行病学和医院环境中实施的控制措施。患者和方法分析2018年1月1日至2018年1月31日期间在国家层面收到的所有HAI-EWRS eXDR报告和NRC收到的所有eXDR菌株。分析的变量为病例数、菌株数、耐药机制、样本类型、与国外的联系以及采取的控制措施。结果2018年,法国共有364家医院和155家医院报告了1704份CPE通报和315份GRE通报,自2012年以来呈上升趋势(CPE为× 6, GRE为× 3) (CPE为+66%,GRE为+57%)。eXDR菌株主要从直肠筛查拭子中分离。与入院时接受接触性预防措施的患者相比,接受标准预防措施的患者的通报更常与疫情相关。2018年NRC共收到CPE菌株2674株,GRE菌株775株,分别比2012年增加8.3株和2.8株。结论NRC每年收到的eXDR报告数量和菌株数量的增加是多因素的,但反映出eXDR在法国的传播令人担忧。感染的数量仍然很低,但本文表明,现有的建议没有得到充分实施。
{"title":"Emerging extensively drug-resistant bacteria (eXDR) in France in 2018","authors":"M. Colomb-Cotinat ,&nbsp;S. Soing-Altrach ,&nbsp;A. Leon ,&nbsp;Y. Savitch ,&nbsp;I. Poujol ,&nbsp;T. Naas ,&nbsp;V. Cattoir ,&nbsp;A. Berger-Carbonne ,&nbsp;L. Dortet ,&nbsp;the CPIAS network","doi":"10.1016/j.medmal.2020.01.011","DOIUrl":"10.1016/j.medmal.2020.01.011","url":null,"abstract":"<div><h3>Objective</h3><p>This 2018 report of Healthcare-Associated Infections Early Warning and Response System (HAI-EWRS) notifications of carbapenemase-producing Enterobacteriaceae (CPE) or glycopeptide-resistant <em>Enterococcus faecium</em> (GRE), and of strains analysed by the National Reference Center for anti-microbial resistance (NRC) aimed to describe the epidemiology of emerging extensively drug-resistant bacteria (eXDR) in France and control measures implemented in hospital settings.</p></div><div><h3>Patients and methods</h3><p>All HAI-EWRS notifications of eXDR received at the national level and all eXDR strains received at the NRC between January 1, 2018 and January 31, 2018 were analysed. Variables analysed were number of cases, number of strains, resistance mechanism, sample type, link with a foreign country, and control measures implemented.</p></div><div><h3>Results</h3><p>In 2018, 1704 CPE notifications and 315 GRE notifications were reported in France, with an increasing trend since 2012 (×<!--> <!-->6 for CPE, ×<!--> <!-->3 for GRE), from respectively 364 and 155 hospitals (+66% for CPE, +57% for GRE since 2012). eXDR strains were mainly isolated from rectal screening swabs. Notifications with patients receiving standard precautions were more often associated with outbreaks than notifications with patients receiving contact precautions at admission. NRC received 2674 CPE strains and 775 GRE strains in 2018 (×<!--> <!-->8.3 and ×<!--> <!-->2.8 compared with 2012).</p></div><div><h3>Conclusion</h3><p>The increasing annual number of eXDR notifications and eXDR strains received by the NRC is multifactorial but reflects a worrying spread of eXDR in France. The number of infections remains low, but this article shows that existing recommendations are not fully implemented.</p></div>","PeriodicalId":18464,"journal":{"name":"Medecine et maladies infectieuses","volume":"50 8","pages":"Pages 715-722"},"PeriodicalIF":5.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.medmal.2020.01.011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37691034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Respiratory failure secondary to cytomegalovirus-associated acute transverse myelitis in an immunocompetent adult 免疫功能正常成人巨细胞病毒相关急性横贯脊髓炎继发呼吸衰竭
IF 5 Q3 Medicine Pub Date : 2020-11-01 DOI: 10.1016/j.medmal.2020.07.001
M.Y. Matta , M. Ghoussoub
{"title":"Respiratory failure secondary to cytomegalovirus-associated acute transverse myelitis in an immunocompetent adult","authors":"M.Y. Matta ,&nbsp;M. Ghoussoub","doi":"10.1016/j.medmal.2020.07.001","DOIUrl":"10.1016/j.medmal.2020.07.001","url":null,"abstract":"","PeriodicalId":18464,"journal":{"name":"Medecine et maladies infectieuses","volume":"50 8","pages":"Pages 751-752"},"PeriodicalIF":5.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.medmal.2020.07.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38149588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Factors associated with treatment failure after advice from infectious disease specialists 传染病专家建议后治疗失败的相关因素
IF 5 Q3 Medicine Pub Date : 2020-11-01 DOI: 10.1016/j.medmal.2019.11.003
A. Martin , Y. Ruch , N. Douiri , P. Boyer , X. Argemi , Y. Hansmann , N. Lefebvre

Objective

Risk factors associated with treatment failure after the infectious disease specialist's (IDS) advice remain unknown. We aimed to identify these risk factors.

Methods

We included patients hospitalized in our tertiary care center who consulted an infectious disease specialist between January 2013 and April 2015. Treatment failure was defined by a composite criterion: signs of sepsis beyond Day 3, ICU admission, or death. Treatment success was defined by the patient's sustained clinical improvement.

Results

A total of 240 IDS recommendations were made. Diagnosis was changed for 64 patients (26.7%) and 50 patients experienced treatment failure after the IDS advice. In multivariate analysis, compliance with the IDS advice was associated with a higher rate of success (OR = 0.09, 95%CI [0.01–0.67]). Variables associated with treatment failure in the multivariate analysis were Charlson comorbidity score at admission (OR = 1.24, 95%CI [1.03–1.50]), a history of infection or colonization with multidrug-resistant bacteria (OR = 8.27, 95%CI [1.37–49.80]), and deterioration of the patient's status three days after the IDS advice (OR = 12.50, 95%CI [3.16–49.46]).

Conclusion

Reassessing IDS recommendations could be interesting for specific patients to further adapt and improve them.

目的:传染病专科医生(IDS)建议后治疗失败的相关风险因素尚不清楚。我们的目标是确定这些风险因素。方法纳入2013年1月至2015年4月在我院三级保健中心就诊并咨询过传染病专家的患者。治疗失败由一个综合标准定义:脓毒症症状超过3天,ICU入院或死亡。治疗成功的定义是患者的持续临床改善。结果共提出了240条IDS建议。64例(26.7%)患者的诊断发生改变,50例患者在接受IDS建议后治疗失败。在多变量分析中,遵从IDS建议与较高的成功率相关(OR = 0.09, 95%CI[0.01-0.67])。多因素分析中与治疗失败相关的变量为入院时Charlson合并症评分(OR = 1.24, 95%CI[1.03-1.50])、感染或多药耐药菌定植史(OR = 8.27, 95%CI[1.37-49.80])以及IDS建议后3天患者病情恶化(OR = 12.50, 95%CI[3.16-49.46])。结论重新评估IDS建议对特定患者有重要意义,可进一步适应和改进IDS建议。
{"title":"Factors associated with treatment failure after advice from infectious disease specialists","authors":"A. Martin ,&nbsp;Y. Ruch ,&nbsp;N. Douiri ,&nbsp;P. Boyer ,&nbsp;X. Argemi ,&nbsp;Y. Hansmann ,&nbsp;N. Lefebvre","doi":"10.1016/j.medmal.2019.11.003","DOIUrl":"10.1016/j.medmal.2019.11.003","url":null,"abstract":"<div><h3>Objective</h3><p>Risk factors associated with treatment failure after the infectious disease specialist's (IDS) advice remain unknown. We aimed to identify these risk factors.</p></div><div><h3>Methods</h3><p>We included patients hospitalized in our tertiary care center who consulted an infectious disease specialist between January 2013 and April 2015. Treatment failure was defined by a composite criterion: signs of sepsis beyond Day 3, ICU admission, or death. Treatment success was defined by the patient's sustained clinical improvement.</p></div><div><h3>Results</h3><p>A total of 240 IDS recommendations were made. Diagnosis was changed for 64 patients (26.7%) and 50 patients experienced treatment failure after the IDS advice. In multivariate analysis, compliance with the IDS advice was associated with a higher rate of success (OR<!--> <!-->=<!--> <!-->0.09, 95%CI [0.01–0.67]). Variables associated with treatment failure in the multivariate analysis were Charlson comorbidity score at admission (OR<!--> <!-->=<!--> <!-->1.24, 95%CI [1.03–1.50]), a history of infection or colonization with multidrug-resistant bacteria (OR<!--> <!-->=<!--> <!-->8.27, 95%CI [1.37–49.80]), and deterioration of the patient's status three days after the IDS advice (OR<!--> <!-->=<!--> <!-->12.50, 95%CI [3.16–49.46]).</p></div><div><h3>Conclusion</h3><p>Reassessing IDS recommendations could be interesting for specific patients to further adapt and improve them.</p></div>","PeriodicalId":18464,"journal":{"name":"Medecine et maladies infectieuses","volume":"50 8","pages":"Pages 696-701"},"PeriodicalIF":5.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.medmal.2019.11.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76148497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infections due to carbapenemase-producing bacteria, clinical burden, and impact of screening strategies on outcome 碳青霉烯酶产生细菌引起的感染、临床负担和筛查策略对结果的影响
IF 5 Q3 Medicine Pub Date : 2020-11-01 DOI: 10.1016/j.medmal.2019.12.011
Louise Abramowicz , Michèle Gerard , Delphine Martiny , Marc Delforge , Stéphane De Wit , Deborah Konopnicki

Objectives

To characterize the risk factors, impact of screening, and clinical burden of colonization and/or infection by carbapenemase-producing bacteria (CPB) in hospitalized patients.

Method

Retrospective study in a tertiary care hospital between 2008 and 2016.

Results

Among 88 included patients, 41% were colonized, 59% developed an infection, and 69% of all cases were hospital-acquired. Risk factors for CPB contamination included recent invasive medical device (94% of patients), antibiotic therapy (82%), travel abroad (17%), and hospitalization (> 50%) with 80% of all patients with underlying chronic condition. Intestinal carriage represented 89% of all colonization cases and 50% of infections were located in the urinary tract. The recent use of mechanical ventilation devices was significantly more observed in infected patients than colonized patients. The most frequent CPB was Klebsiella pneumoniae and the most frequent carbapenemase was OXA-48. Overall mortality rate was 19%. Prevalence of CPB detection in intensive care units (ICU) based on systematical rectal screen swab upon admission remained < 0.5%. The infected/colonized ratio (CPB colonization cases evolving into an infection) was 23%. The time between CPB infection diagnosis and start of appropriate antimicrobial therapy increased from 1 day in previously screened patients with positive CPB to 4 days in patients with previous negative or absent screening.

Conclusion

Our results emphasize the importance of CPB screening in all ICU patients and in at-risk patients hospitalized in other units, to allow earlier adequate antibiotic therapy in case of infection which occurred in 23% of the colonized patients.

目的探讨住院患者碳青霉烯酶产菌(CPB)定植和/或感染的危险因素、筛查的影响和临床负担。方法2008 - 2016年在某三级医院进行回顾性研究。结果88例患者中,41%定植,59%发生感染,69%为医院获得性感染。CPB污染的危险因素包括近期侵入性医疗器械(94%的患者)、抗生素治疗(82%)、出国旅行(17%)和住院(>50%), 80%的患者有潜在的慢性疾病。肠道占所有定植病例的89%,50%的感染位于尿路。近期使用机械通气装置的感染患者明显多于定植患者。最常见的CPB是肺炎克雷伯菌,最常见的碳青霉烯酶是OXA-48。总死亡率为19%。重症监护病房(ICU)入院时系统直肠筛查拭子检测CPB的流行率保持不变。0.5%。感染/定植比率(CPB定植病例演变为感染)为23%。CPB感染诊断和开始适当抗菌药物治疗之间的时间从先前筛查的CPB阳性患者的1天增加到先前筛查阴性或未筛查的患者的4天。结论我们的研究结果强调了在所有ICU患者和其他单位住院的高危患者中进行CPB筛查的重要性,以便在23%的定群患者发生感染时及早给予充分的抗生素治疗。
{"title":"Infections due to carbapenemase-producing bacteria, clinical burden, and impact of screening strategies on outcome","authors":"Louise Abramowicz ,&nbsp;Michèle Gerard ,&nbsp;Delphine Martiny ,&nbsp;Marc Delforge ,&nbsp;Stéphane De Wit ,&nbsp;Deborah Konopnicki","doi":"10.1016/j.medmal.2019.12.011","DOIUrl":"10.1016/j.medmal.2019.12.011","url":null,"abstract":"<div><h3>Objectives</h3><p>To characterize the risk factors, impact of screening, and clinical burden of colonization and/or infection by carbapenemase-producing bacteria (CPB) in hospitalized patients.</p></div><div><h3>Method</h3><p>Retrospective study in a tertiary care hospital between 2008 and 2016.</p></div><div><h3>Results</h3><p>Among 88 included patients, 41% were colonized, 59% developed an infection, and 69% of all cases were hospital-acquired. Risk factors for CPB contamination included recent invasive medical device (94% of patients), antibiotic therapy (82%), travel abroad (17%), and hospitalization (&gt;<!--> <!-->50%) with 80% of all patients with underlying chronic condition. Intestinal carriage represented 89% of all colonization cases and 50% of infections were located in the urinary tract. The recent use of mechanical ventilation devices was significantly more observed in infected patients than colonized patients. The most frequent CPB was <em>Klebsiella pneumoniae</em> and the most frequent carbapenemase was OXA-48. Overall mortality rate was 19%. Prevalence of CPB detection in intensive care units (ICU) based on systematical rectal screen swab upon admission remained &lt;<!--> <!-->0.5%. The infected/colonized ratio (CPB colonization cases evolving into an infection) was 23%. The time between CPB infection diagnosis and start of appropriate antimicrobial therapy increased from 1 day in previously screened patients with positive CPB to 4 days in patients with previous negative or absent screening.</p></div><div><h3>Conclusion</h3><p>Our results emphasize the importance of CPB screening in all ICU patients and in at-risk patients hospitalized in other units, to allow earlier adequate antibiotic therapy in case of infection which occurred in 23% of the colonized patients.</p></div>","PeriodicalId":18464,"journal":{"name":"Medecine et maladies infectieuses","volume":"50 8","pages":"Pages 658-664"},"PeriodicalIF":5.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.medmal.2019.12.011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37624524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Factors affecting physicians’ perception of the overuse of antibiotics 影响医生对抗生素过度使用认知的因素
IF 5 Q3 Medicine Pub Date : 2020-11-01 DOI: 10.1016/j.medmal.2020.01.006
Y. Camcioglu , D. Sener Okur , N. Aksaray , F. Darendeliler , E. Hasanoglu

Objective

We aimed to determine the reasons for irrational antibiotic use, to evaluate knowledge, attitudes, and behaviors of physicians regarding such use, to find factors affecting knowledge of physicians, and to explore precautions that need to be taken to stop irrational antibiotic use.

Material and methods

We performed the study between January 2014 and June 2014. We included 202 physicians who answered a questionnaire with 22 multiple-choice questions about knowledge (eight questions), behavior and attitudes of physicians (nine questions), and recommendations for reducing antibiotic consumption (five questions). Answers to all questions were assessed according to the physician's age, educational status, metropolitan areas, and healthcare facilities.

Results

The effects of parents’ expectations and satisfaction (7.4%–40.0%) (P < 0.0001) and socioeconomical status of families (33%–62%) (P = 0.007) increased as the participants’ age decreased. Participants working at public hospitals (42.6%) considered expectations and satisfaction of parents more important than other participants (10.5%–26.9%; P = 0.002). Rapid recovery of patients was not an essential determinant for administering antibiotics for pediatricians (25.7%) and pediatric assistants (26.9%). However, it was important for emergency physicians (55.6%) and family physicians (60%, P = 0.016). Physicians working at university hospitals did not consider this determinant as important as physicians working in other healthcare facilities (P = 0.001).

Conclusion

To determine the obstacles associated with promoting rational antibiotic usage, every country should assess the attitudes, behavior, and knowledge of physicians related to such use. The present study is one of the few in Turkey to address the problems associated with irrational antibiotic use.

目的了解不合理使用抗生素的原因,评价医生对不合理使用抗生素的知识、态度和行为,寻找影响医生知识的因素,探讨停止不合理使用抗生素需要采取的预防措施。材料与方法本研究于2014年1月至2014年6月进行。我们纳入了202名医生,他们回答了一份包含22个选择题的问卷,其中包括知识(8个问题)、医生的行为和态度(9个问题)以及减少抗生素使用的建议(5个问题)。根据医生的年龄、教育程度、城市地区和医疗机构对所有问题的答案进行评估。结果家长期望和满意度对小学生学业成绩的影响(7.4% ~ 40.0%)(P <0.0001),家庭社会经济地位(33% ~ 62%)(P = 0.007)随着年龄的下降而增加。在公立医院工作的受访者(42.6%)认为父母的期望和满意度比其他受访者(10.5%-26.9%)更重要;p = 0.002)。对于儿科医生(25.7%)和儿科助理(26.9%)来说,患者的快速恢复并不是使用抗生素的必要决定因素。但急诊医师(55.6%)和家庭医师(60%,P = 0.016)对这一问题的认识较重要。在大学医院工作的医生不认为这一决定因素与在其他医疗机构工作的医生一样重要(P = 0.001)。结论为确定促进合理使用抗生素的障碍,各国应评估医生对抗生素使用的态度、行为和知识。目前的研究是土耳其为数不多的解决与不合理抗生素使用相关问题的研究之一。
{"title":"Factors affecting physicians’ perception of the overuse of antibiotics","authors":"Y. Camcioglu ,&nbsp;D. Sener Okur ,&nbsp;N. Aksaray ,&nbsp;F. Darendeliler ,&nbsp;E. Hasanoglu","doi":"10.1016/j.medmal.2020.01.006","DOIUrl":"10.1016/j.medmal.2020.01.006","url":null,"abstract":"<div><h3>Objective</h3><p>We aimed to determine the reasons for irrational antibiotic use, to evaluate knowledge, attitudes, and behaviors of physicians regarding such use, to find factors affecting knowledge of physicians, and to explore precautions that need to be taken to stop irrational antibiotic use.</p></div><div><h3>Material and methods</h3><p>We performed the study between January 2014 and June 2014. We included 202 physicians who answered a questionnaire with 22 multiple-choice questions about knowledge (eight questions), behavior and attitudes of physicians (nine questions), and recommendations for reducing antibiotic consumption (five questions). Answers to all questions were assessed according to the physician's age, educational status, metropolitan areas, and healthcare facilities.</p></div><div><h3>Results</h3><p>The effects of parents’ expectations and satisfaction (7.4%–40.0%) (<em>P</em> <!-->&lt;<!--> <!-->0.0001) and socioeconomical status of families (33%–62%) (<em>P</em> <!-->=<!--> <!-->0.007) increased as the participants’ age decreased. Participants working at public hospitals (42.6%) considered expectations and satisfaction of parents more important than other participants (10.5%–26.9%; <em>P</em> <!-->=<!--> <!-->0.002). Rapid recovery of patients was not an essential determinant for administering antibiotics for pediatricians (25.7%) and pediatric assistants (26.9%). However, it was important for emergency physicians (55.6%) and family physicians (60%, <em>P</em> <!-->=<!--> <!-->0.016). Physicians working at university hospitals did not consider this determinant as important as physicians working in other healthcare facilities (<em>P</em> <!-->=<!--> <!-->0.001).</p></div><div><h3>Conclusion</h3><p>To determine the obstacles associated with promoting rational antibiotic usage, every country should assess the attitudes, behavior, and knowledge of physicians related to such use. The present study is one of the few in Turkey to address the problems associated with irrational antibiotic use.</p></div>","PeriodicalId":18464,"journal":{"name":"Medecine et maladies infectieuses","volume":"50 8","pages":"Pages 652-657"},"PeriodicalIF":5.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.medmal.2020.01.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37634788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
期刊
Medecine et maladies infectieuses
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1